Boditech Med Inc. (KOSDAQ:206640)

Market Cap	306.82B
Revenue (ttm)	144.17B
Net Income (ttm)	27.86B
Shares Out	21.79M
EPS (ttm)	1,272.37
PE Ratio	11.07
Forward PE	8.73
Dividend	150.00 (1.07%)
Ex-Dividend Date	Mar 31, 2025

Volume	185,014
Average Volume	109,833
Open	14,290
Previous Close	14,230
Day's Range	13,890 - 14,310
52-Week Range	13,350 - 21,050
Beta	0.36
RSI	23.49
Earnings Date	Aug 11, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 515
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.